相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Involvement of placental growth factor upregulated via TGF-β1-ALK1-Smad1/5 signaling in prohaptoglobin-induced angiogenesis
Mi-Kyung Oh et al.
PLOS ONE (2019)
Heparanase regulation of sFLT-1 release in trophoblasts in vitro
Adrian C. Eddy et al.
PLACENTA (2019)
Heparin Differentially Impacts Gene Expression of Stromal Cells from Various Tissues
Sandra Laner-Plamberger et al.
SCIENTIFIC REPORTS (2019)
Effects of glycol-split low molecular weight heparin on placental, endothelial, and anti-inflammatory pathways relevant to preeclampsia
Jovian M. Wat et al.
BIOLOGY OF REPRODUCTION (2018)
Low molecular weight heparin for the prevention of severe preeclampsia: where next?
Kelsey McLaughlin et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Re: Predicting delivery of a small-for-gestational-age infant and adverse perinatal outcome in women with suspected pre-eclampsia
J. C. Kingdom
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2018)
Full Functional Knockout of Placental Growth Factor by Knockin with an Inactive Variant Able to Heterodimerize with VEGF-A
Ivana Apicella et al.
CELL REPORTS (2018)
Low Molecular Weight Heparin Improves Endothelial Function in Pregnant Women at High Risk of Preeclampsia
Kelsey McLaughlin et al.
HYPERTENSION (2017)
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia
Daniel L. Rolnik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Novel Heparin Receptor Transmembrane Protein 184a Regulates Angiogenesis in the Adult Zebrafish Caudal Fin
Sara Lynn N. Farwell et al.
FRONTIERS IN PHYSIOLOGY (2017)
Placental Growth Factor Reduces Blood Pressure in a Uteroplacental Ischemia Model of Preeclampsia in Nonhuman Primates
Angela Makris et al.
HYPERTENSION (2016)
Maternal Cardiovascular Function in Normal Pregnancy Evidence of Maladaptation to Chronic Volume Overload
Karen Melchiorre et al.
HYPERTENSION (2016)
Placental Growth Factor Administration Abolishes Placental Ischemia-Induced Hypertension
Frank T. Spradley et al.
HYPERTENSION (2016)
Sustained dual release of placental growth factor-2 and bone morphogenic protein-2 from heparin-based nanocomplexes for direct osteogenesis
Yun Liu et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2016)
Transmembrane Protein 184A Is a Receptor Required for Vascular Smooth Muscle Cell Responses to Heparin
Raymond J. Pugh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Prevention of pre-eclampsia by low-molecular-weight heparin in addition to aspirin: a meta-analysis
S. Roberge et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2016)
Cigarette smoke extract induces placental growth factor release from human bronchial epithelial cells via ROS/MAPK (ERK-1/2)/Egr-1 axis
Dong Wu et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2016)
Low-molecular-weight heparin protects kidney through an anti-apoptotic mechanism in a rat pre-eclamptic model
Yuan Zhang et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2015)
Low molecular weight heparin therapy during pregnancy is associated with elevated circulatory levels of placental growth factor
Y. Yinon et al.
PLACENTA (2015)
Early Pregnancy Prediction of Preeclampsia in Nulliparous Women, Combining Clinical Risk and Biomarkers The Screening for Pregnancy Endpoints (SCOPE) International Cohort Study
Louise C. Kenny et al.
HYPERTENSION (2014)
Low-Molecular Weight Heparin Increases Circulating sFlt-1 Levels and Enhances Urinary Elimination
Henning Hagmann et al.
PLOS ONE (2014)
Diagnostic Accuracy of Placental Growth Factor in Women With Suspected Preeclampsia A Prospective Multicenter Study
Lucy C. Chappell et al.
CIRCULATION (2013)
Can placental growth factor in maternal circulation identify fetuses with placental intrauterine growth restriction?
Samantha J. Benton et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2012)
Post-transcriptional regulation of placenta growth factor mRNA by hydrogen peroxide
Jennifer H. Shaw et al.
MICROVASCULAR RESEARCH (2012)
Placenta growth factor expression is regulated by hydrogen peroxide in vascular smooth muscle cells
Jennifer H. Shaw et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2011)
Heparin Strongly Induces Soluble Fms-Like Tyrosine Kinase 1 Release In Vivo and In Vitro-Brief Report
Julia Searle et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Placental Growth Factor Regulates Cardiac Adaptation and Hypertrophy Through a Paracrine Mechanism
Federica Accornero et al.
CIRCULATION RESEARCH (2011)
Local Retention Versus Systemic Release of Soluble VEGF Receptor-1 Are Mediated by Heparin-Binding and Regulated by Heparanase
Shay Sela et al.
CIRCULATION RESEARCH (2011)
Heparin promotes soluble VEGF receptor expression in human placental villi to impair endothelial VEGF signaling
S. Drewlo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Molecular Regulation of Human Placental Growth Factor (PIGF) Gene Expression in Placental Villi and Trophoblast Cells is Mediated via the Protein Kinase A Pathway
Christophe Depoix et al.
REPRODUCTIVE SCIENCES (2011)
Role of Vimentin in the Inhibitory Effects of Low-Molecular-Weight Heparin on PC-3M Cell Adhesion to, and Migration through, Endothelium
Yan Pan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Potential Role for Plasma Placental Growth Factor in Predicting Coronary Heart Disease Risk in Women
Aedin Cassidy et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Effect of Recombinant Placental Growth Factor 2 on Hypertension Induced by Full-Length Mouse Soluble fms-Like Tyrosine Kinase 1 Adenoviral Vector in Pregnant Mice
Hirotada Suzuki et al.
HYPERTENSION (2009)
Total vascular resistance and left ventricular morphology as screening tools for complications in pregnancy
Barbara Vasapollo et al.
HYPERTENSION (2008)
Increased myeloperoxidase in the placenta and circulation of women with preeclampsia
Robin E. Gandley et al.
HYPERTENSION (2008)
Heparin and fibroblast growth factors affect surfactant protein gene expression in type II cells
Kevin A. Leiner et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2006)
Placental growth factor provides a novel local angiogenic therapy for ischemic cardiomyopathy
Stephen Kolakowski et al.
JOURNAL OF CARDIAC SURGERY (2006)
Heparins increase endothelial nitric oxide bioavailability by liberating vessel-immobilized myeloperoxidase
S Baldus et al.
CIRCULATION (2006)
Elevated placental growth factor levels are associated with adverse outcomes at four-year follow-up in patients with acute coronary syndromes
T Lenderink et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Comparison of the vasodilatory effect of nadroparin, enoxaparin, dalteparin, and unfractioned heparin in human internal mammary artery
A Tasatargil et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2005)
Placental growth factor promotes atherosclerotic intimal thickening and macrophage accumulation
R Khurana et al.
CIRCULATION (2005)
Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women
G Mello et al.
HYPERTENSION (2005)
Circulating angiogenic factors and the risk of preeclampsia
RJ Levine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Enoxaparin - low molecular weight heparin, restores the altered vascular reactivity of resistance arteries in aged and aged-diabetic hamsters
A Georgescu et al.
VASCULAR PHARMACOLOGY (2003)
Transcriptional activation of placental growth factor by the forkhead/winged helix transcription factor FoxD1
H Zhang et al.
CURRENT BIOLOGY (2003)
分享论文
